Abbvie Inc. vs Amgen Inc
ABBV vs AMGN — side-by-side comparison from reported financials. ABBV leads 5, AMGN leads 7 of 12 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
Amgen Inc
AMGN · Healthcare
$415.01+1.86%Mixed
| Metric | ABBV | AMGN |
|---|---|---|
| Price | $276.43 | $415.01 |
| Market cap | $488B | $224B |
| Revenue (TTM) | $64.4B | $38.1B |
| Revenue growth | +1.8% | +11.8% |
| Net margin | 9.8% | 23.0% |
| Free cash flow | $18.2B | $10.2B |
| Net cash (debt) | ($56.2B) | ($40.9B) |
| 1-year price return | +19.8% | +40.5% |
| P/E | 77.4 | 25.7 |
| P/E vs own history (cheap-side %) | 23% | 35% |
| Dividend yield | 2.45% | 2.32% |
| Return on equity | 96% | 89% |
| Altman Z-score | 2.33 | 1.81 |
| CV checks passed | 9 of 11 | 11 of 11 |
| Employees | 57,000 | 31,500 |
Full résumé-style profiles: ABBV CV · AMGN CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.